-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$65.5013.34% Upside
Recent Analyst Forecasts and Stock Ratings
Bristol-Myers Squibb Company Frequently Asked Questions
-
What analysts cover Bristol-Myers Squibb Company?
Bristol-Myers Squibb Company has been rated by research analysts at BMO Capital, Goldman Sachs, Barclays, UBS, Cowen & Co., Deutsche Bank in the past 90 days.